Clinical Research Directory
Browse clinical research sites, groups, and studies.
Neuroprotective Impact of Dexmedetomidine Versus Propofol on Intracranial Pressure Monitoring in Adult Traumatic Brain Injury Patients
Sponsor: Assiut University
Summary
To investigate whether dexmedetomidine or propofol is more effective in controlling intracranial pressure (ICP) (assessed via optic nerve sheath diameter "ONSD" as a primary outcome) and which is more effective in suppressing lipid peroxidation (measured via malondialdehyde "MDA" as a secondary outcome). This double-blind randomized controlled trial aims to bridge this research gap by evaluating the biochemical neuroprotective efficacy alongside the clinical outcomes of both agents in TBI patients.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-10-01
Completion Date
2028-01-01
Last Updated
2026-09-08
Healthy Volunteers
No
Conditions
Interventions
Propofol
evaluate intracranial pressure and serum Malondialdehyde (MDA) levels
Dexmedetomidine
evaluate intracranial pressure and serum Malondialdehyde (MDA) levels